Brett K Haumann - Net Worth and Insider Trading
Brett K Haumann Net Worth
The estimated net worth of Brett K Haumann is at least $3 Million dollars as of 2024-04-24. Brett K Haumann is the Chief Medical Officer of Theravance Biopharma Inc and owns about 282,810 shares of Theravance Biopharma Inc (TBPH) stock worth over $3 Million. Details can be seen in Brett K Haumann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brett K Haumann has not made any transactions after 2020-08-21 and currently still holds the listed stock(s).
Transaction Summary of Brett K Haumann
Brett K Haumann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brett K Haumann owns 2 companies in total, including Aimmune Therapeutics Inc (AIMT) , and Theravance Biopharma Inc (TBPH) .
Click here to see the complete history of Brett K Haumann’s form 4 insider trades.
Insider Ownership Summary of Brett K Haumann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2020-10-10 | director |
| TBPH | Theravance Biopharma Inc | 2020-08-21 | VP-Clinical Develop. |
Brett K Haumann Latest Holdings Summary
Brett K Haumann currently owns a total of 1 stock. Brett K Haumann owns 282,810 shares of Theravance Biopharma Inc (TBPH) as of August 21, 2020, with a value of $3 Million.
Latest Holdings of Brett K Haumann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TBPH | Theravance Biopharma Inc | 2020-08-21 | 282,810 | 9.21 | 2,604,680 |
Holding Weightings of Brett K Haumann
Brett K Haumann Form 4 Trading Tracker
According to the SEC Form 4 filings, Brett K Haumann has made a total of 1 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Theravance Biopharma Inc is the sale of 25,000 shares on August 21, 2020, which brought Brett K Haumann around $457,250.
Insider Trading History of Brett K Haumann
- 1
Brett K Haumann Trading Performance
Brett K Haumann Ownership Network
Ownership Network List of Brett K Haumann
Ownership Network Relation of Brett K Haumann
Brett K Haumann Owned Company Details
What does Aimmune Therapeutics Inc do?
Who are the key executives at Aimmune Therapeutics Inc?
Brett K Haumann is the director of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and Chief Medical Officer Adelman Daniel C Md .
Aimmune Therapeutics Inc (AIMT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aimmune Therapeutics Inc Insider Transactions
Brett K Haumann Mailing Address
Above is the net worth, insider trading, and ownership report for Brett K Haumann. You might contact Brett K Haumann via mailing address: 901 Gateway Blvd, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
